Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Ocular Therapeutix (OCUL) over the last 11 years, with Q3 2025 value amounting to $183.9 million.

  • Ocular Therapeutix's Shares Outstanding (Weighted Average) rose 1013.64% to $183.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.9 million, marking a year-over-year increase of 1013.64%. This contributed to the annual value of $60.8 million for FY2020, which is 3419.02% up from last year.
  • As of Q3 2025, Ocular Therapeutix's Shares Outstanding (Weighted Average) stood at $183.9 million, which was up 1013.64% from $172.6 million recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Shares Outstanding (Weighted Average) registered a high of $183.9 million during Q3 2025, and its lowest value of $77.4 million during Q1 2023.
  • Over the past 3 years, Ocular Therapeutix's median Shares Outstanding (Weighted Average) value was $166.4 million (recorded in 2024), while the average stood at $143.3 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 11246.59% in 2024, then soared by 408.26% in 2025.
  • Ocular Therapeutix's Shares Outstanding (Weighted Average) (Quarter) stood at $78.0 million in 2023, then soared by 113.96% to $167.0 million in 2024, then increased by 10.14% to $183.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $183.9 million in Q3 2025, compared to $172.6 million in Q2 2025 and $169.4 million in Q1 2025.